Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold)

Rapid, self-performing, qualitative two-site sandwich immunoassay based on lateral-flow immunochromatography; a cassette contains dye (collo

Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) product packaging
Medical Device

Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold)

Rapid, self-performing, qualitative two-site sandwich immunoassay based on lateral-flow immunochromatography; a cassette contains dye (colloidal gold)-labelled antibodies on a nitrocellulose strip with test lines and a control line [1][3].
The device detects P. falciparum-specific (HRP2) and P. vivax-specific (pLDH) antigens in human whole blood; separate test lines allow P. falciparum, P. vivax and mixed infections to be distinguished [1][3].
Kit contents per pouch: one test cassette with pre-dispensed monoclonal antibody conjugates and a desiccant; assay buffer and a sample transfer device are supplied; a calibrated micropipette (5 µL) may be used instead of the loop [3].
Blood obtained by finger-prick is applied to the sample well, buffer is added to the buffer well, and results are read within about 15-30 minutes [1][2][3].

Product NameMalaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold)
Dosage FormMalaria Test Kit
Strength25 Tests · 1 Test per Pouch
StandardsBP / ENTERPRISE
Packing25 Tests · 1 Test per Pouch
DocumentsCOA, COPP, DMF, CTD Dossiers
MOQContact us for MOQ and current stock
Request Quotation › ← Back to Medical Device
WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾
For in vitro diagnostic use: qualitative detection and differentiation of P. falciparum and P. vivax malaria in patients with suspected malaria (febrile illness) [1][2][3]. Useful for rapid, point-of-care diagnosis where reliable microscopy is not immediately available, including remote and community-level settings; WHO recommends prompt parasite-based diagnosis in all suspected cases before treatment [1][2]. The kit is an aid to diagnosis; microscopy remains the gold standard and should be used to confirm RDT results, identify species and quantify parasitaemia wherever feasible [1][2].
💧Administration▾
Specimen: fresh finger-prick capillary blood or fresh anticoagulated whole blood (EDTA, heparin or oxalate); do not use clotted, haemolysed or contaminated samples [3]. If testing is not immediate, store the whole blood specimen at 2-8 °C for up to 72 hours; do not freeze [3]. Bring kit and specimen to room temperature; open the foil pouch, collect about 5 µL of blood with the sample loop (or micropipette) and apply it to the sample well, then add the buffer drops to the buffer well as stated in the insert [3]. Read the result within the time window given in the insert (typically 15-20 minutes); do not interpret the test beyond 30 minutes [3]. Operators should be trained and monitored on test preparation and interpretation; follow the local standard operating procedure and job-aids [1].
⚖️Dosage▾
Sample volume: approximately 5 µL of whole blood per test; buffer volume as specified in the package insert (typically about 2 drops) [3]. Test results are qualitative; the Pv line may also be used to monitor the response of a stand-alone P. vivax infection to anti-malarial therapy [3].
⚠️Precautions & Warnings▾
For professional in vitro diagnostic use only; the device is not intended for self-testing by patients or the general public [2]. Do not use the test beyond the expiry date, if the pouch is damaged or opened, or if the desiccant is missing; use a new device for each test [3]. Store the kit at 4-30 °C (or per the approved label) until the expiry date; do not freeze; avoid exposure to high temperature and humidity during transport and storage [1][3]. The RDT may miss infections with very low parasite densities; sensitivity depends on parasite density. All negative results should be confirmed by microscopy when feasible [1][2]. All positive results should also be confirmed by microscopy to determine the species and parasitaemia, an important prognostic indicator [2]. False-negative results are possible with P. falciparum strains lacking pfhrp2/3 genes; selection should consider tests meeting WHO performance criteria (panel detection score, false-positive and invalid rates) [1]. Handle blood specimens with universal precautions; dispose of lancets, cassettes and specimens safely as biohazardous waste [3]. For full product information, refer to the approved package insert / labelling of the product concerned [1][2][3].

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) — Frequently Asked Questions

Which documents are provided for Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) registration?

Every batch of Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold)?

MOQ and lead time for Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold), subject to the regulatory requirements of the destination market.

Which markets have you exported medical device products to?

We have supplied medical device products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) controlled?

Malaria Pf/Pv Antigen Rapid Test Kit (Colloidal Gold) is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›
✎ 💬 ↑
👋 Hi! I'm Care, your product guide. Tap me to ask about our medicines & APIs. ×
Care - product guide assistant